The global pravastatin market is projected to reach a staggering USD 1.3 billion by 2027, driven by rising awareness of cholesterol-related health issues and an aging population. This presents a lucrative opportunity for pravastatin manufacturers and suppliers to connect with established buyers and expand their reach. Our curated list of global pravastatin buyers features reputable companies from various regions, including: North America: McKesson Corporation, Cardinal Health, AmerisourceBergen Europe: Alliance Healthcare, Phoenix Group, Teva Pharmaceutical Industries Asia Pacific: Hong Kong Shanghai Pharmacy, Zuellig Pharma, Cipla Latin America: Drogaria Onofre, Farmacias Benavides, Farmacias Ahumada Beyond the List: Market Insights and Connection Strategies This guide goes beyond simply providing a list of buyers.…